These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 18688786)

  • 1. Cancer genetic testing: current and emerging issues.
    Patenaude AF; Julian-Reynier C
    Psychooncology; 2008 Aug; 17(8):733-6. PubMed ID: 18688786
    [No Abstract]   [Full Text] [Related]  

  • 2. Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.
    James PA; Harris M; Lindeman GJ; Mitchell G
    J Med Genet; 2008 Nov; 45(11):765-6. PubMed ID: 18978334
    [No Abstract]   [Full Text] [Related]  

  • 3. Can genetic testing guide treatment in breast cancer?
    Tutt A; Ashworth A
    Eur J Cancer; 2008 Dec; 44(18):2774-80. PubMed ID: 19027287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
    Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
    Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on genetic predisposition to breast cancer.
    Ahmed M; Lalloo F; Evans DG
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1103-13. PubMed ID: 19671030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary tumor development in dogs is associated with BRCA1 and BRCA2.
    Rivera P; Melin M; Biagi T; Fall T; Häggström J; Lindblad-Toh K; von Euler H
    Cancer Res; 2009 Nov; 69(22):8770-4. PubMed ID: 19887619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary breast cancer: from bench to bedside.
    De Grève J; Sermijn E; De Brakeleer S; Ren Z; Teugels E
    Curr Opin Oncol; 2008 Nov; 20(6):605-13. PubMed ID: 18841041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers.
    Matloff ET; Barnett RE; Bober SL
    Cancer J; 2009; 15(1):15-8. PubMed ID: 19197168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advantages of the high resolution melting in the detection of BRCA1 or BRCA2 mutation carriers.
    Jiménez Ide J; Esteban Cardeñosa E; Palanca Suela S; González EB; Bolufer Gilabert P;
    Clin Biochem; 2009 Oct; 42(15):1572-6. PubMed ID: 19616529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers.
    Maehle L; Apold J; Paulsen T; Hagen B; Løvslett K; Fiane B; Van Ghelue M; Clark N; Møller P
    Clin Cancer Res; 2008 Nov; 14(22):7569-73. PubMed ID: 19010876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
    Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The variants BRCA1 IVS6-1G>A and BRCA2 IVS15+1G>A lead to aberrant splicing of the transcripts.
    Gutiérrez-Enríquez S; Coderch V; Masas M; Balmaña J; Diez O
    Breast Cancer Res Treat; 2009 Sep; 117(2):461-5. PubMed ID: 18712473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic services have value beyond BRCA1/2 testing.
    Hall MJ
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):686. PubMed ID: 19208665
    [No Abstract]   [Full Text] [Related]  

  • 16. Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk.
    Yang R; Chen B; Hemminki K; Wappenschmidt B; Engel C; Sutter C; Ditsch N; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
    Breast Cancer Res Treat; 2009 Nov; 118(2):407-13. PubMed ID: 19229607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and in silico analysis of BRCA1 and BRCA2 variants.
    Tommasi S; Pilato B; Pinto R; Monaco A; Bruno M; Campana M; Digennaro M; Schittulli F; Lacalamita R; Paradiso A
    Mutat Res; 2008 Sep; 644(1-2):64-70. PubMed ID: 18694767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetrance of BRCA1/BRCA2 specific gene mutations in Iranian women with breast cancer.
    Hashemian AH; Hajizadeh E; Kazemnejad A; Atri M; Mehdipour P
    Saudi Med J; 2009 Jan; 30(1):41-4. PubMed ID: 19139771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coping with genetic testing for breast cancer susceptibility.
    Dougall AL; Smith AW; Somers TJ; Posluszny DM; Rubinstein WS; Baum A
    Psychosom Med; 2009 Jan; 71(1):98-105. PubMed ID: 19124622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing for cancer susceptibility.
    Calzone KA; Soballe PW
    Surg Clin North Am; 2008 Aug; 88(4):705-21, v. PubMed ID: 18672137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.